Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
02/14/2023 08:30 EST Earnings Call Q4 2022 -- -- --
02/14/2023 -- Results Q4 2022 -- 0.65 --
10/27/2022 08:30 EST Earnings Call Q3 2022 -- -- --
10/27/2022 -- Results Q3 2022 0.66 0.59 12.82%
07/28/2022 -- Results Q2 2022 0.59 0.51 14.94%
07/28/2022 08:30 EST Earnings Call Q2 2022 -- -- --
05/02/2022 -- Results Q1 2022 0.40 0.38 6.67%
05/02/2022 08:30 EST Earnings Call Q1 2022 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 02/14/2023
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 10/27/2022
Beat/Miss Upgrade
Return Since 2.93%
Last FQE 09/30/2022
Next FQE 12/30/2022

Profile

Edit
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.
URL https://www.inmodemd.com
Investor Relations URL https://inmodemd.com/investors/
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 14, 2023
Last Earnings Release Oct. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2016
2017
2018
2019
2020
2021
2022
YTD
--
--
--
--
21.12%
197.3%
-49.42%
4.31%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-18.11%
7.86%
-18.49%
-37.81%
-14.87%
-82.45%
-46.06%
-27.53%
-52.48%
-35.56%
--
--
--
--
-34.12%
-74.92%
-88.33%
103.5%
-20.19%
-50.98%
-13.20%
174.7%
103.2%
-64.49%
-83.36%
34.13%
26.55%
-3.50%
-42.89%
-50.01%
79.44%
-79.35%
-35.61%
13.82%
As of February 03, 2023.

Profile

Edit
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, Evolve, Evoke, and Morpheus8. The majority of its revenue comes from the United States.
URL https://www.inmodemd.com
Investor Relations URL https://inmodemd.com/investors/
HQ State/Province N/A
Sector Healthcare
Industry Medical Devices
Equity Style Mid Cap/Growth
Next Earnings Release Feb. 14, 2023
Last Earnings Release Oct. 27, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
ITEQ 3.313M USD 2.75%
JSJCX 10.76M USD 2.46%
IZRL 2.468M USD 2.22%
NGM360 8.954M USD 2.17%
WRGCX 30.10M USD 2.05%
PNSBX 16.66M USD 1.97%
ASCYX 6.551M USD 1.68%
ISRA 930292.0 USD 1.47%
ANTSX 6.916M USD 1.43%
EIS 2.216M USD 1.42%
VIDI 1.997M USD 0.54%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Nasdaq Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter INMD Tweets